chr6-24423599-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020662.4(MRS2):āc.1237A>Gā(p.Lys413Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000999 in 1,602,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020662.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRS2 | NM_020662.4 | c.1237A>G | p.Lys413Glu | missense_variant | 11/11 | ENST00000378386.8 | NP_065713.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRS2 | ENST00000378386.8 | c.1237A>G | p.Lys413Glu | missense_variant | 11/11 | 1 | NM_020662.4 | ENSP00000367637 | P1 | |
MRS2 | ENST00000443868.6 | c.1246A>G | p.Lys416Glu | missense_variant | 12/12 | 2 | ENSP00000399585 | |||
MRS2 | ENST00000274747.11 | c.1087A>G | p.Lys363Glu | missense_variant | 9/9 | 2 | ENSP00000274747 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249298Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134854
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1450066Hom.: 0 Cov.: 27 AF XY: 0.00000277 AC XY: 2AN XY: 722110
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.1237A>G (p.K413E) alteration is located in exon 11 (coding exon 11) of the MRS2 gene. This alteration results from a A to G substitution at nucleotide position 1237, causing the lysine (K) at amino acid position 413 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at